Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

GnRH treatment can reduce breast cancer cell invasion.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.